EAM
IGMS

Erste Asset Management’s IGM Biosciences IGMS Stock Holding History

Erste Asset Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,500
Closed -$189K – 561
2021
Q4 		$189K Hold
6,500
– – ﹤0.01% 495
2021
Q3 		$432K Hold
6,500
– – 0.01% 433
2021
Q2 		$543K Hold
6,500
– – 0.01% 400
2021
Q1 		$488K Hold
6,500
– – 0.01% 388
2020
Q4 		$576K Buy
+6,500
New +$457K 0.02% 375

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Erste Asset Management's IGMS Position: Q1 2022 in Review

Erste Asset Management sold out of IGM Biosciences (IGMS) in Q1 2022, closing a stake of 6,500 shares — an estimated $189K sold.

Erste Asset Management first reported a position in IGMS in Q4 2020 and held it in 5 quarters. The position peaked at $576K in Q4 2020. 93 funds tracked by Wall St. Rank hold IGMS as of Q1 2022.

  • Erste Asset Management reported no remaining IGM Biosciences position as of Q1 2022 after selling out during the quarter.
  • Erste Asset Management sold 6,500 IGM Biosciences shares in Q1 2022, an estimated $189K.
  • Erste Asset Management first reported a position in IGM Biosciences in Q4 2020 and held it in 5 quarters.
  • Erste Asset Management's IGM Biosciences position peaked at $576K in Q4 2020.
  • 93 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2022.

Based on Erste Asset Management's 13F filing for Q1 2022, filed 25 Nov 2024.